BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11588147)

  • 1. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
    Teixeira J; Maheswaran S; Donahoe PK
    Endocr Rev; 2001 Oct; 22(5):657-74. PubMed ID: 11588147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR
    Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mullerian inhibiting substance: an update.
    MacLaughlin DT; Donahoe PK
    Adv Exp Med Biol; 2002; 511():25-38; discussion 38-40. PubMed ID: 12575754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic studies of MIS signalling in sexual development.
    Jamin SP; Arango NA; Mishina Y; Behringer RR
    Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian inhibiting substance in reproduction and cancer.
    Donahoe PK
    Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
    Fynn-Thompson E; Cheng H; Teixeira J
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing and irreversibility of Müllerian duct inhibition in the embryonic reproductive tract of the human male.
    Taguchi O; Cunha GR; Lawrence WD; Robboy SJ
    Dev Biol; 1984 Dec; 106(2):394-8. PubMed ID: 6548718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
    Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
    Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into mullerian inhibiting substance and its mechanism of action.
    Lane AH; Donahoe PK
    J Endocrinol; 1998 Jul; 158(1):1-6. PubMed ID: 9713320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
    Roberts LM; Visser JA; Ingraham HA
    Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum müllerian inhibiting substance assay--a new diagnostic test for disorders of gonadal development.
    Forest MG
    N Engl J Med; 1997 May; 336(21):1519-21. PubMed ID: 9154774
    [No Abstract]   [Full Text] [Related]  

  • 20. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.